Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network

Tahlita C.M. Zuiverloon, Kim E.M. van Kessel, Trinity J. Bivalacqua, Joost L. Boormans, Thorsten H. Ecke, Petros D. Grivas, Anne E. Kiltie, Fredrik Liedberg, Andrea Necchi, Bas W. van Rhijn, Florian Roghmann, Marta Sanchez-Carbayo, Bernd J. Schmitz-Dräger, Felix Wezel, Ashish M. Kamat*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)

Abstract

Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is often left to infer on what the preferred follow-up schema would be for an individual patient. Herein, we aim to synthesize recommendations for follow-up of patients with MIBC for easy reference. Methods: A multidisciplinary MIBC expert panel from the International Bladder Cancer Network was assembled to critically assess currently available major guidelines on surveillance of MIBC patients. Recommendations for follow-up were extracted and critically evaluated. Important considerations for guideline assessment included both aspects of oncological and functional follow-up—frequency of visits, the use of different imaging modalities, the role of cytology and molecular markers, and the duration of follow-up. Outcome: An International Bladder Cancer Network expert consensus recommendation was constructed for the follow-up of patients with MIBC based on the currently available evidence-based data.

Original languageEnglish
Pages (from-to)423-431
Number of pages9
JournalUrologic Oncology: Seminars and Original Investigations
Volume36
Issue number9
DOIs
Publication statusPublished - Sep 2018

Keywords

  • Bladder cancer
  • Disease management
  • Follow-up
  • Guidelines
  • Muscle invasive

Fingerprint Dive into the research topics of 'Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network'. Together they form a unique fingerprint.

Cite this